Featuring: publicly traded & venture capital companies on the U.S. (NYSE, NASDAQ, AMEX & OTC: BB) and Canadian (TSX & TSX-V) stock exchanges, Investment & Money Management Ideas.

Press Release - Accuray Incorporated (ARAY-NASDAQ)

wpe11.jpg (7184 bytes)

“If you are a patient, you should remember that Accuray’s CyberKnife is an alternative to surgery. It’s a non-invasive, painless out-patient procedure. The Cyberknife can treat inoperable tumors, and even if operable, you don’t want to cut open the patient, crack open their rib cage, and deflate their lungs in order to treat a lung tumor or invasively treat a tumor that is wrapped around the spine. It may be inoperable in that case.  Our technology offers the means to deliver high doses of radiation...” - Robert E. McNamara (ARAY) (Interview published May 30, 2008)

The Most Powerful Name In Corporate News and Information.

CURRENT ISSUE |  COVER ARCHIVES  |  INDEX  |  CONTACT  |  FINANCIALS |  SERVICES  | HOME PAGE


CEOCFO-Members Login
Become A Member!



 
Accuray Incorporated's CEO to Speak at 27th Annual JP Morgan Healthcare Conference

SUNNYVALE, Calif., Dec. 30 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its president and chief executive officer, Euan S. Thomson, Ph.D., is scheduled to present at the 27th Annual JP Morgan Healthcare Conference in San Francisco, on Wednesday, January 14, 2009 at 11:30 a.m. PST (2:30 p.m. EST).

A live webcast of the presentation will be available online from the investor relations page of the Company's Web site at http://www.accuray.com. The webcast replay of the presentation will begin approximately one hour after the conclusion of the live presentation and will be available for approximately 30 days.

About the CyberKnife(R) Robotic Radiosurgery System

The CyberKnife Robotic Radiosurgery System is the world's only robotic radiosurgery system designed to treat tumors anywhere in the body non-invasively. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver high-dose radiation with pinpoint precision, which minimizes damage to surrounding healthy tissue and eliminates the need for invasive head or body stabilization frames.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 50,000 patients worldwide and currently more than 150 systems have been installed in leading hospitals in the Americas, Europe and Asia. For more information, please visit http://www.accuray.com.

SOURCE  Accuray Incorporated

    -0-                             12/30/2008
    /CONTACT:  Investors, Tom Rathjen, Vice President, Investor Relations,
+1-408-789-4458, trathjen@accuray.com, or media, Stephanie Tomei, Manager,
Public Relations, +1-408-789-4234, stomei@accuray.com, both of Accuray
Incorporated/
    /Web site:  http://www.accuray.com /
    (ARAY)

CO:  Accuray Incorporated

ST:  California
IN:  HEA BIO FIN
SU:  TDS CCA

JD-JP
-- AQTU002 --
0874 12/30/2008 08:30 EST http://www.prnewswire.com


			
 

		

		
    


    

    
	

        

    

  







ceocfointerviews.com does not purchase or
make 

recommendation on stocks based on the interviews published.